Form D · Other Health Care
STX Molecular Laboratories, LLC
Plano, TX · CIK 0001626736
Offering snapshot reported Dec 3, 2014 · SEC filing
- Reported sold
- $82.5K Offering amount: $150K
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $3.75K Reported outside-investor minimum
- First sale
- Nov 18, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2014 | Initial | $82,500 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-229336
Source: Form D, filed Dec 3, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Warren Stabiler, Jr. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
610 Coit Road Suite 200 A
Plano, TX, 75075
Plano, TX, 75075